Shopping Cart 0
Cart Subtotal
USD 0

JCR Pharmaceuticals Co Ltd (4552) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

JCR Pharmaceuticals Co Ltd (JCR) manufactures, sells, buys, imports and exports pharmaceutical products. It provides biopharmaceuticals in the field of regenerative medicine for the treatment of rare diseases. The company offers pharmaceuticals to treat growth hormone deficiency, turner syndrome, adult growth hormone deficiency, small for gestational age, renal anemia in dialysis patients and anemia of prematurity; and a regenerative medical product for acute graft-versus-host disease. JCR is also involved in the purchasing, selling, import and export of medical devices and laboratory instruments. It operates subsidiaries in Japan, Switzerland and the US. JCR is headquartered in Ashiya, Hyogo, Japan.

JCR Pharmaceuticals Co Ltd (4552)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

JCR Pharmaceuticals Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Plasticell Enters Into Licensing Agreement With JCR Pharma For CombiCult 11

NanoCarrier Enters into Agreement with JCR Pharma 12

JCR Pharma Plans to Form Joint Venture with MediPal 13

JCR Pharma Enters into Agreement with Eisai 14

Kissei Pharma Enters Into Co-Development Agreement With JCR Pharma 15

Licensing Agreements 16

JCR Pharma Enters into Licensing Agreement with Mesoblast 16

Sumitomo Dainippon Pharma Enters into Licensing Agreement with JCR Pharma 17

Teijin Enters into Licensing Agreement with JCR Pharma for JTR-161 18

Acquisition 19

MediPal Plans to Acquire 22% Stake in JCR Pharma from Glaxo Group for USD189.7 Million 19

JCR Pharmaceuticals Co Ltd-Key Competitors 20

JCR Pharmaceuticals Co Ltd-Key Employees 21

JCR Pharmaceuticals Co Ltd-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 24

Strategy And Business Planning 24

Apr 26, 2018: JCR Announces Construction of the Second Clinical Trial Material Manufacturing Center 24

Product News 25

10/26/2017: JCR to Initiate Development of JR-171, a New Drug Candidate for Hurler Syndrome Using J-Brain Cargo 25

09/14/2018: JCR to initiate development of a new drug candidate for sanfilippo syndrome Type A using J-Brain Cargo 26

03/31/2017: JCR Announces First Patient Dosed in Phase 1/2 Clinical Trial of JR-141 in Hunter Syndrome 27

02/17/2017: JCR Announces Data Presentation on the Efficacy of BBB-Penetrating IDS on CNS in MPS II Mouse Model at the 13th Annual WORLDSymposium 2017 28

Clinical Trials 29

Jan 19, 2017: JCR announces completion of PMDA review of clinical trial plan for JR-141 29

Appendix 30

Methodology 30

About GlobalData 30

Contact Us 30

Disclaimer 30


List Of Figure

List of Figures

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

JCR Pharmaceuticals Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

JCR Pharmaceuticals Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8

JCR Pharmaceuticals Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Plasticell Enters Into Licensing Agreement With JCR Pharma For CombiCult 11

NanoCarrier Enters into Agreement with JCR Pharma 12

JCR Pharma Plans to Form Joint Venture with MediPal 13

JCR Pharma Enters into Agreement with Eisai 14

Kissei Pharma Enters Into Co-Development Agreement With JCR Pharma 15

JCR Pharma Enters into Licensing Agreement with Mesoblast 16

Sumitomo Dainippon Pharma Enters into Licensing Agreement with JCR Pharma 17

Teijin Enters into Licensing Agreement with JCR Pharma for JTR-161 18

MediPal Plans to Acquire 22% Stake in JCR Pharma from Glaxo Group for USD189.7 Million 19

JCR Pharmaceuticals Co Ltd, Key Competitors 20

JCR Pharmaceuticals Co Ltd, Key Employees 21

JCR Pharmaceuticals Co Ltd, Other Locations 22

JCR Pharmaceuticals Co Ltd, Subsidiaries 22

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

JCR Pharmaceuticals Co Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

JCR Pharmaceuticals Co Ltd (JCR) manufactures, sells, buys, imports and exports pharmaceutical products. It provides biopharmaceuticals in the field of regenerative medicine for the treatment of rare diseases. The company offers pharmaceuticals to treat growth hormone deficiency, turner syndrome, adult growth hormone deficiency, small for gestational age, renal anemia in dialysis patients and anemia of prematurity; and a regenerative medical product for acute graft-versus-host disease. JCR is also involved in the purchasing, selling, import and export of medical devices and laboratory instruments. It operates subsidiaries in Japan, Switzerland and the US. JCR is headquartered in Ashiya, Hyogo, Japan.

JCR Pharmaceuticals Co Ltd (4552)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

JCR Pharmaceuticals Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Plasticell Enters Into Licensing Agreement With JCR Pharma For CombiCult 11

NanoCarrier Enters into Agreement with JCR Pharma 12

JCR Pharma Plans to Form Joint Venture with MediPal 13

JCR Pharma Enters into Agreement with Eisai 14

Kissei Pharma Enters Into Co-Development Agreement With JCR Pharma 15

Licensing Agreements 16

JCR Pharma Enters into Licensing Agreement with Mesoblast 16

Sumitomo Dainippon Pharma Enters into Licensing Agreement with JCR Pharma 17

Teijin Enters into Licensing Agreement with JCR Pharma for JTR-161 18

Acquisition 19

MediPal Plans to Acquire 22% Stake in JCR Pharma from Glaxo Group for USD189.7 Million 19

JCR Pharmaceuticals Co Ltd-Key Competitors 20

JCR Pharmaceuticals Co Ltd-Key Employees 21

JCR Pharmaceuticals Co Ltd-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 24

Strategy And Business Planning 24

Apr 26, 2018: JCR Announces Construction of the Second Clinical Trial Material Manufacturing Center 24

Product News 25

10/26/2017: JCR to Initiate Development of JR-171, a New Drug Candidate for Hurler Syndrome Using J-Brain Cargo 25

09/14/2018: JCR to initiate development of a new drug candidate for sanfilippo syndrome Type A using J-Brain Cargo 26

03/31/2017: JCR Announces First Patient Dosed in Phase 1/2 Clinical Trial of JR-141 in Hunter Syndrome 27

02/17/2017: JCR Announces Data Presentation on the Efficacy of BBB-Penetrating IDS on CNS in MPS II Mouse Model at the 13th Annual WORLDSymposium 2017 28

Clinical Trials 29

Jan 19, 2017: JCR announces completion of PMDA review of clinical trial plan for JR-141 29

Appendix 30

Methodology 30

About GlobalData 30

Contact Us 30

Disclaimer 30


List Of Figure

List of Figures

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

JCR Pharmaceuticals Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

JCR Pharmaceuticals Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8

JCR Pharmaceuticals Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Plasticell Enters Into Licensing Agreement With JCR Pharma For CombiCult 11

NanoCarrier Enters into Agreement with JCR Pharma 12

JCR Pharma Plans to Form Joint Venture with MediPal 13

JCR Pharma Enters into Agreement with Eisai 14

Kissei Pharma Enters Into Co-Development Agreement With JCR Pharma 15

JCR Pharma Enters into Licensing Agreement with Mesoblast 16

Sumitomo Dainippon Pharma Enters into Licensing Agreement with JCR Pharma 17

Teijin Enters into Licensing Agreement with JCR Pharma for JTR-161 18

MediPal Plans to Acquire 22% Stake in JCR Pharma from Glaxo Group for USD189.7 Million 19

JCR Pharmaceuticals Co Ltd, Key Competitors 20

JCR Pharmaceuticals Co Ltd, Key Employees 21

JCR Pharmaceuticals Co Ltd, Other Locations 22

JCR Pharmaceuticals Co Ltd, Subsidiaries 22

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

JCR Pharmaceuticals Co Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.